Literature DB >> 26317441

Local infiltration of rabies immunoglobulins without systemic intramuscular administration: An alternative cost effective approach for passive immunization against rabies.

Omesh Kumar Bharti1, Shampur Narayan Madhusudana2, Pyare Lal Gaunta3, Ashwin Yajaman Belludi4.   

Abstract

Presently the dose of rabies immunoglobulin (RIG) which is an integral part of rabies post exposure prophylaxis (PEP) is calculated based on body weight though the recommendation is to infiltrate the wound(s). This practice demands large quantities of RIG which may be unaffordable to many patients. In this background, we conducted this study to know if the quantity and cost of RIG can be reduced by restricting passive immunization to local infiltration alone and avoiding systemic intramuscular administration based on the available scientific evidence. Two hundred and sixty nine category III patients bitten by suspect or confirmed rabid dogs/animals were infiltrated with equine rabies immunoglobulin (ERIGs) in and around the wound. The quantity of ERIG used was proportionate to the size and number of wounds irrespective of their body weight. They were followed with a regular course of rabies vaccination by intra-dermal route. As against 363 vials of RIGs required for all these cases as per current recommendation based on body weight, they required only 42 vials of 5ml RIG. Minimum dose of RIGs given was 0.25 ml and maximum dose given was 8 ml. On an average 1.26 ml of RIGs was required per patient that costs Rs. 150 ($3). All the patients were followed for 9 months and they were healthy and normal at the end of observation period. With local infiltration, that required small quantities of RIG, the RIGs could be made available to all patients in times of short supply in the market. A total of 30 (11%) serum samples of patients were tested for rabies virus neutralizing antibodies by the rapid fluorescent focus inhibition test (RFFIT) and all showed antibody titers >0.5 IU/mL by day 14. In no case the dose was higher than that required based on body weight and no immunosuppression resulted. To conclude, this pilot study shows that local infiltration of RIG need to be considered in times of non-availability in the market or unaffordability by poor patients. This preliminary study needs to be done on larger scale in other centers with long term follow up to substantiate the results of our study.

Entities:  

Keywords:  animal bites; passive immunization; rabies; rabies immunoglobulin

Mesh:

Substances:

Year:  2016        PMID: 26317441      PMCID: PMC4964710          DOI: 10.1080/21645515.2015.1085142

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  9 in total

1.  Diffusion and fate of intramuscularly injected human rabies immune globulin.

Authors:  N Saesow; T Chaiwatanarat; C Mitmoonpitak; H Wilde
Journal:  Acta Trop       Date:  2000-10-02       Impact factor: 3.112

2.  Studies on the local treatment of rabies-infected wounds.

Authors:  D J DEAN; G M BAER; W R THOMPSON
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

3.  Failures of post-exposure rabies prophylaxis.

Authors:  Henry Wilde
Journal:  Vaccine       Date:  2007-09-14       Impact factor: 3.641

4.  Use of hyperimmune anti-rabies serum concentrates in experimental rabies.

Authors:  H KOPROWSKI; J VAN DER SCHEER; J BLACK
Journal:  Am J Med       Date:  1950-04       Impact factor: 4.965

5.  Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. 4.

Authors:  P Atanasiu; D J Dean; K Habel; M M Kaplan; H Koprowski; P Lépine; C Serié
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

6.  Excretion of rabies virus in the saliva of dogs.

Authors:  M Fekadu; J H Shaddock; G M Baer
Journal:  J Infect Dis       Date:  1982-05       Impact factor: 5.226

7.  Feasibility of reducing rabies immunoglobulin dosage for passive immunization against rabies: results of In vitro and In vivo studies.

Authors:  Shampur Narayan Madhusudana; Belludi Yajaman Ashwin; Sampada Sudarshan
Journal:  Hum Vaccin Immunother       Date:  2013-06-21       Impact factor: 3.452

8.  Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey.

Authors:  M K Sudarshan; S N Madhusudana; B J Mahendra; N S N Rao; D H Ashwath Narayana; S Abdul Rahman; F -X Meslin; D Lobo; K Ravikumar
Journal:  Int J Infect Dis       Date:  2006-05-04       Impact factor: 3.623

Review 9.  Survival from rabies encephalitis.

Authors:  Aaron de Souza; Shampur Narayan Madhusudana
Journal:  J Neurol Sci       Date:  2014-02-20       Impact factor: 3.181

  9 in total
  12 in total

1.  Injecting rabies immunoglobulin (RIG) into wounds only: A significant saving of lives and costly RIG.

Authors:  Omesh Kumar Bharti; Shampur Narayan Madhusudana; Henry Wilde
Journal:  Hum Vaccin Immunother       Date:  2017-02-22       Impact factor: 3.452

2.  Failure of postexposure prophylaxis in a girl child attacked by rabid dog severing her facial nerve causing possible direct entry of rabies virus into the facial nerve.

Authors:  Omesh Kumar Bharti; Daleep Tekta; Ambuj Shandil; Kalpana Sharma; Piyush Kapila
Journal:  Hum Vaccin Immunother       Date:  2019-05-22       Impact factor: 3.452

3.  Implementation of Clinical Decision Support on Emergency Department Delivery of Human Rabies Immune Globulin.

Authors:  Fangzheng Yuan; Tomona Iso; Elsie Rizk; R Benjamin Saldana; Anh Thu Tran; Ngoc-Anh A Nguyen; Prasanth R Boyareddigari; Daniela Espino; Joshua T Swan
Journal:  JAMA Netw Open       Date:  2022-06-01

4.  Safety and efficacy of rabies immunoglobulin in pediatric patients with suspected exposure.

Authors:  Nicholas Hobart-Porter; Michal Stein; Naveh Toh; Novinyo Amega; Huy-Binh Nguyen; James Linakis
Journal:  Hum Vaccin Immunother       Date:  2021-02-09       Impact factor: 4.526

5.  Defining the volume of rabies immunoglobulins/ rabies monoclonal antibodies requirement for wound infiltration of category III animal exposures - an exploratory study.

Authors:  Ravish S Haradanhalli; Nitu Kumari; Mysore K Sudarshan; D H Ashwath Narayana; Ramya M Prashanth; Jithin Surendran
Journal:  Hum Vaccin Immunother       Date:  2022-01-21       Impact factor: 3.452

Review 6.  Lyssaviruses and rabies: current conundrums, concerns, contradictions and controversies.

Authors:  Charles Rupprecht; Ivan Kuzmin; Francois Meslin
Journal:  F1000Res       Date:  2017-02-23

7.  "Scratches/Abrasions without Bleeding" Cause Rabies: A 7 Years Rabies Death Review from Medical College Shimla, Himachal Pradesh, India.

Authors:  Omesh Kumar Bharti; Ramesh Chand; Anjali Chauhan; Rahul Rao; Hamender Sharma; Archana Phull
Journal:  Indian J Community Med       Date:  2017 Oct-Dec

8.  Adherence to guideline recommendations for human rabies immune globulin patient selection, dosing, timing, and anatomical site of administration in rabies postexposure prophylaxis.

Authors:  Grace S Hwang; Elsie Rizk; Lan N Bui; Tomona Iso; Emily I Sartain; Anh Thu Tran; Joshua T Swan
Journal:  Hum Vaccin Immunother       Date:  2019-08-01       Impact factor: 3.452

9.  Modelling to inform prophylaxis regimens to prevent human rabies.

Authors:  Katie Hampson; Bernadette Abela-Ridder; Omesh Bharti; Lea Knopf; Monique Léchenne; Rolande Mindekem; Arnaud Tarantola; Jakob Zinsstag; Caroline Trotter
Journal:  Vaccine       Date:  2018-12-07       Impact factor: 4.169

10.  Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial.

Authors:  Mark A Matson; Eran Schenker; Michal Stein; Vladislava Zamfirova; Huy-Binh Nguyen; Garrett E Bergman
Journal:  Hum Vaccin Immunother       Date:  2019-09-24       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.